Literature DB >> 15358255

Cysteine peptidases as virulence factors of Leishmania.

Jeremy C Mottram1, Graham H Coombs, James Alexander.   

Abstract

Leishmania mexicana amastigotes are particularly rich in cysteine peptidases (CPs), which play important roles in facilitating the survival and growth of the parasites in mammals. The importance of the CPs as virulence factors and their potential as drug targets and vaccine candidates has been investigated extensively. Recent years, however, have heralded advances in our knowledge and understanding of leishmanial CPs on two fronts. Firstly, genome analysis has revealed the great diversity of CPs, and, secondly, the ways in which the most widely studied CPs, designated CPB, influence the interaction between parasite and mammalian host have been elucidated. These topics are the focus of this review.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15358255     DOI: 10.1016/j.mib.2004.06.010

Source DB:  PubMed          Journal:  Curr Opin Microbiol        ISSN: 1369-5274            Impact factor:   7.934


  72 in total

1.  Calcium-dependent proteolytic activity of a cysteine protease caldonopain is detected during Leishmania infection.

Authors:  Runu Dey; Jharna Bhattacharya; Salil C Datta
Journal:  Mol Cell Biochem       Date:  2006-01       Impact factor: 3.396

2.  Study of protein complexes via homology modeling, applied to cysteine proteases and their protein inhibitors.

Authors:  Ozlem Tastan Bishop; Matthys Kroon
Journal:  J Mol Model       Date:  2011-03-02       Impact factor: 1.810

3.  Aziridine-2,3-dicarboxylates, peptidomimetic cysteine protease inhibitors with antileishmanial activity.

Authors:  Alicia Ponte-Sucre; Radim Vicik; Martina Schultheis; Tanja Schirmeister; Heidrun Moll
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

4.  Comparative study of the ability of Leishmania mexicana promastigotes and amastigotes to alter macrophage signaling and functions.

Authors:  Issa Abu-Dayyeh; Kasra Hassani; Edze R Westra; Jeremy C Mottram; Martin Olivier
Journal:  Infect Immun       Date:  2010-04-05       Impact factor: 3.441

Review 5.  Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view.

Authors:  Martin Olivier; David J Gregory; Geneviève Forget
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

6.  Cysteine proteinases from promastigotes of Leishmania (Viannia) braziliensis.

Authors:  Karina M Rebello; Luzia M C Côrtes; Bernardo A S Pereira; Bernardo M O Pascarelli; Suzana Côrte-Real; Léa C Finkelstein; Rosa T Pinho; Claudia M d'Avila-Levy; Carlos R Alves
Journal:  Parasitol Res       Date:  2009-09-24       Impact factor: 2.289

7.  Molecular and biochemical characterization of a cathepsin B-like protease family unique to Trypanosoma congolense.

Authors:  Carlos Mendoza-Palomares; Nicolas Biteau; Christiane Giroud; Virginie Coustou; Theresa Coetzer; Edith Authié; Alain Boulangé; Théo Baltz
Journal:  Eukaryot Cell       Date:  2008-02-15

8.  Identification of Leishmania proteins preferentially released in infected cells using change mediated antigen technology (CMAT).

Authors:  Peter E Kima; J Alfredo Bonilla; Eumin Cho; Blaise Ndjamen; Johnathan Canton; Nicole Leal; Martin Handfield
Journal:  PLoS Negl Trop Dis       Date:  2010-10-05

9.  Development of a New Antileishmanial Aziridine-2,3-Dicarboxylate-Based Inhibitor with High Selectivity for Parasite Cysteine Proteases.

Authors:  Caroline Schad; Ulrike Baum; Benjamin Frank; Uwe Dietzel; Felix Mattern; Carlos Gomes; Alicia Ponte-Sucre; Heidrun Moll; Uta Schurigt; Tanja Schirmeister
Journal:  Antimicrob Agents Chemother       Date:  2015-11-23       Impact factor: 5.191

10.  Influence of parasite encoded inhibitors of serine peptidases in early infection of macrophages with Leishmania major.

Authors:  Sylvain C P Eschenlauer; Marilia S Faria; Lesley S Morrison; Nicolas Bland; Flavia L Ribeiro-Gomes; George A DosReis; Graham H Coombs; Ana Paula C A Lima; Jeremy C Mottram
Journal:  Cell Microbiol       Date:  2008-10-29       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.